Sustained retroviral gene marking and expression in lymphoid and myeloid cells derived from transduced hematopoietic progenitor cells
- PMID: 8854097
Sustained retroviral gene marking and expression in lymphoid and myeloid cells derived from transduced hematopoietic progenitor cells
Abstract
The expression of antiviral genes in human hematopoietic stem or progenitor cells has been proposed as a strategy for gene therapy of AIDS. To be successful, this strategy requires safe and efficient transfer of the therapeutic gene into hematopoietic cells and gene expression has to be maintained in HIV susceptible cells following differentiation. We have used retroviral vectors to transfer the gene for a transdominant inhibitor of HIV replication (RevM10) into CD34+ stem/progenitor cells isolated from human umbilical cord blood (UCB). Following transduction, cells were allowed to differentiate either in vitro in clonogenic assays and long-term stromal cell cultures or in human thymus implanted in immunodeficient scid/scid mice in vivo (SCID-hu). Following differentiation and expansion, multiple lineages of cells were shown to carry the transgene. A higher percentage of gene-marked progenitor cells (10-30% in most cases) were detected in methylcellulose colony assays and in long-term stromal cell cultures (1-5%). In contrast, gene-marked T cells derived from transduced CD34+ cells in a SCID-hu model were detected at an even lower frequency (0.01-1%). RevM10 RNA expression was detected in CD34+ cells immediately after transduction and was maintained after in vitro differentiation of those cells into CD14+ myeloid cells. In T cells, the RevM10-specific RNA was detectable by RT-PCR and also by semiquantitative RNase protection. These findings demonstrate that LTR-driven gene expression is sustained in relevant cells derived from retrovirus-transduced hematopoietic progenitor cells after extensive differentiation in vitro and in vivo and suggest that stringent in vivo, rather than in vitro assays, may be a better preclinical system to improve gene marking and expression in hematopoietic cells.
Similar articles
-
Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.Mol Ther. 2000 Mar;1(3):244-54. doi: 10.1006/mthe.2000.0038. Mol Ther. 2000. PMID: 10933940
-
Highly efficient gene transfer into preterm CD34 hematopoietic progenitor cells.Am J Obstet Gynecol. 2000 Sep;183(3):732-7. doi: 10.1067/mob.2000.106752. Am J Obstet Gynecol. 2000. PMID: 10992201
-
Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.J Gene Med. 2004 Oct;6(10):1049-60. doi: 10.1002/jgm.609. J Gene Med. 2004. PMID: 15386735
-
Thy-1-expressing CD34+ human cells express multiple hematopoietic potentialities in vitro and in SCID-hu mice.Nouv Rev Fr Hematol (1978). 1993 Feb;35(1):91-3. Nouv Rev Fr Hematol (1978). 1993. PMID: 7685521 Review.
-
The sheep model of in utero gene therapy.Fetal Diagn Ther. 2004 Jan-Feb;19(1):23-30. doi: 10.1159/000074255. Fetal Diagn Ther. 2004. PMID: 14646413 Review.
Cited by
-
Integrin alphaIIb promoter-targeted expression of gene products in megakaryocytes derived from retrovirus-transduced human hematopoietic cells.Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9654-9. doi: 10.1073/pnas.96.17.9654. Proc Natl Acad Sci U S A. 1999. PMID: 10449749 Free PMC article.
-
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma.Sci Transl Med. 2010 Jun 16;2(36):36ra43. doi: 10.1126/scitranslmed.3000931. Sci Transl Med. 2010. PMID: 20555022 Free PMC article. Clinical Trial.
-
RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication.J Virol. 1997 Jun;71(6):4707-16. doi: 10.1128/JVI.71.6.4707-4716.1997. J Virol. 1997. PMID: 9151864 Free PMC article.
-
Scaffold attachment region-mediated enhancement of retroviral vector expression in primary T cells.J Virol. 1998 May;72(5):3720-8. doi: 10.1128/JVI.72.5.3720-3728.1998. J Virol. 1998. PMID: 9557654 Free PMC article.
-
Loss of T cell-mediated antitumor immunity after construct-specific downregulation of retrovirally encoded T-cell receptor expression in vivo.Cancer Gene Ther. 2009 Feb;16(2):171-83. doi: 10.1038/cgt.2008.63. Epub 2008 Aug 8. Cancer Gene Ther. 2009. PMID: 18690205 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials